On Friday we reported that Pfizer was in talks to takeover Wyeth, and over the weekend the $68 Billion deal was finalized. The AP reports that Pfizer is cutting 10% of its workforce, slashing its dividend, and reducing the number of manufacturing sites. Inside sources exclusive to The Daily Anchor are saying that the layoffs will focus on Pfizer’s sales team, and that 50% of its pharmaceutical sales positions will be eliminated to make room for Wyeth.
Posts tagged as:
